The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. Over the ensuing years CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases. CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994.
Since then, CSL has acquired a number of companies. They include: Aventis Behring, which is now known as global biotech leader CSL Behring, U.S. plasma collector Nabi, which helped to form the world's premier plasma collection company in CSL Plasma, the Novartis influenza vaccine business, now integrated and known as Seqirus, the world's second largest influenza vaccines company and Calimmune, a leader in gene-modification and cell delivery technology. Their combined and rich histories make CSL the innovative global leader it is today.
|Type||Public / Private|
|Industry||Biopharmaceutical Health Care|
|Headquarters||King of Prussia, Pennsylvania, USA|
|Key people||Paul Perreault, CEO and Managing Director of CSL Limited|
|Number of employees||20,000+|
Top 5 Recent Tweets
|October 06, 2022||Aris_Global||ArisGlobal’s, Beena Wood, along with panelists Claudia Lehmann of Boehringer Ingelheim, Bethann Riley of Bristol Me… https://t.co/OmXZXkppEG|
|October 06, 2022||TheAsthmaCures||Isaiah Murillo's CSL Plasma Career Journey - CSL Behring https://t.co/SbKRO7G8A2 At 3, he was diagnosed with X-link… https://t.co/Rox1WKCD5f|
|October 05, 2022||CSLBehring||Missed #EHA2022? Catch up on CSL Behring’s symposium “Haemophilia as a blueprint for gene therapy: exploring the im… https://t.co/CT25NJBWsQ|
|October 04, 2022||CSLBehring||CSL Behring's history was inextricably linked to the Nobel Prize in 1901 when Emil von Behring won the first Nobel… https://t.co/RvQ8VGyI3x|